Skip to main content
Clinical Trials/EUCTR2011-001812-80-NL
EUCTR2011-001812-80-NL
Active, not recruiting
Phase 1

on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer. - PET with [18F]HX4

Maastro Clinic0 sites24 target enrollmentNovember 14, 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Maastro Clinic
Enrollment
24
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 14, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Histological or cytological confirmed HNSSC of the oral cavity, oropharynx, hypopharynx, larynx, T2\-T3\-T4, any N, M0
  • \- Tumor (or lymph node) diameter \= 2,5 cm
  • \- WHO performance status 0 to 2
  • \- Scheduled for primary curative (concurrent chemo\-) radiotherapy
  • \- No previous surgery to the head and neck
  • \- No previous radiation to the head and neck
  • \- Adequate renal function (calculated creatinine clearance at least 60 ml/min)
  • \- The patient is willing and capable to comply with study procedures
  • \- 18 years or older
  • \- Have given written informed consent before patien registration

Exclusion Criteria

  • No recent (\< 3 months) myocardial infarction
  • \- No Uncontrolled infectious disease
  • \- Not pregnant or breast feeding and willing to take adequate contraceptive measures during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials